ArticleFrontiers in child and adolescent psychiatry2025
Mortality following adolescent substance treatment: 21-year follow-up from a single clinical site.
Article in Frontiers in child and adolescent psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Mortality among adolescent and young adults in specialized substance use treatment: a Swedish register study.Child and adolescent psychiatry and mental health · 2026Article
- Emotionality Stigma, Sociocultural Factors, and Health Inequities in Urban Adolescents.International journal of environmental research and public health · 2025Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Despite known risks of substance use, mortality following adolescent substance treatment has not been examined. Knowing which youth have greatest risk and how youth die may inform future interventions. Methods: This retrospective chart review combined records from a single adolescent substance treatment program at an urban, safety-net health system ( Results: Overall, 92 (2.1%) adolescents in mental health treatment had a death record compared to 119 (4.0%) of adolescents in substance treatment. The crude mortality rate per 100 person years for adolescents in mental health treatment was 0.19 (CI: 0.18-0.20) compared to 0.37 (CI: 0.36-0.38) for adolescents in substance treatment. The standard mortality rate was 120 (32.7-308) for adolescents in mental health treatment compared to the standardized mortality rate of 944 (CI: 599-1,420) for adolescents in substance treatment. Accidental death, which includes overdose, was the most common cause of death in both groups. Results of the logistic regression showed male sex at birth ( Conclusions: Adolescents in substance treatment compared to those in mental health treatment are more likely to die within 5 years of intake. Males compared to females are also more likely to die. Interventions to prevent overdose and other causes of mortality may be indicated.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.